Maternal-Infant Characteristics and Perinatal Outcomes by Hemolytic Disease of the Fetus and Newborn (HDFN) Status.

被引：0
|
作者：
Getahun, Darios [1 ]
Shi, Jiaxiao [1 ]
Xie, Fagen [1 ]
Im, Theresa [1 ]
Chiu, Vicki [1 ]
Kim, Sunhea [1 ]
Mensah, Nana [1 ]
Fassett, Michael [2 ]
Mao, Carol [3 ]
Alemao, Evo [3 ]
Molaei, Matthew [3 ]
Lin, Iris [4 ]
机构：
[1] Kaiser Permanente Southern Calif, Pasadena, CA USA
[2] Kaiser Permanente West Los Angeles Med Ctr, Los Angeles, CA USA
[3] Janssen Global Serv LLC, Raritan, NJ USA
[4] Janssen Sci Affair LLC, Horsham, PA USA
来源：
REPRODUCTIVE SCIENCES | 2024年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
S-059
引用
收藏
页码：289A / 289A
页数：1
相关论文
共 50 条
  • [41] Management of severe hemolytic disease of the fetus and newborn due to maternal anti-Rh17: Using incompatible blood
    Butt, Henna
    Rich, Colleen
    Webb, Jennifer
    PEDIATRIC BLOOD & CANCER, 2024,
  • [42] Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review
    Blyth, Ursula
    Larsson, Martina
    Baird, Aimi
    Waring, Gareth
    Athiraman, Naveen
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2022, 35 (25): : 10220 - 10225
  • [43] More data needed to establish maternal breast milk IgG as cause for anti-D hemolytic disease of fetus and newborn
    Strauss, Ronald G.
    Storry, Jill R.
    TRANSFUSION, 2018, 58 (03) : 828 - 829
  • [44] Israeli HDFN Study Group Investigators. Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study (vol 60, pg 2684, 2020)
    Rahimi-Levene, N.
    Chezar, J.
    Yahalom, V
    TRANSFUSION, 2022, 62 (07) : 1466 - 1466
  • [45] Employing digital PCR for enhanced detection of perinatal Toxoplasma gondii infection: A cross-sectional surveillance and maternal-infant outcomes study in El Salvador
    Lynn, Mary K.
    Aquino, Marvin Stanley Rodriguez
    Rivas, Pamela Michelle Cornejo
    Miranda, Xiomara
    Torres-Romero, David F.
    Cowan, Hanson
    Meyer, Madeleine M.
    Castro-Godoy, Willber D.
    Kanyangarara, Mufaro
    Self, Stella C. W.
    Campbell, Berry A.
    Nolan, Melissa S.
    PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (05):
  • [46] LATENT HEMOLYTIC DISEASE OF THE NEWBORN INFANT - THE VARIABLE QUANTITATIVE RELATIONSHIP BETWEEN THE AMOUNT OF MATERNAL RH ANTIBODIES AND THE EXTENT OF DAMAGE TO THE RH-POSITIVE INFANT
    GRUNDORFER, J
    JOURNAL OF PEDIATRICS, 1952, 40 (02): : 172 - 179
  • [47] Hemolytic disease of the fetus and newborn in a Chinese blood group Di(a plus b plus ) neonate caused by maternal anti-Dib antibodies
    Wang, Ruyao
    Wan, Yanzhen
    Liu, Li
    Fan, Liangfeng
    Su, Nailun
    Bu, Xiangmao
    TRANSFUSION MEDICINE, 2021, 31 (06) : 501 - 502
  • [48] Obstetric significance of anti-Jra :: Study of twenty pregnancy outcomes showing three cases of severe hemolytic disease of the fetus and newborn
    Peyrard, T.
    Pham, B-N
    Arnaud, L.
    Brossard, Y.
    Cortey, A.
    Carbonne, B.
    Cartron, J-P
    Rouger, P.
    Le Pennec, P-Y
    TRANSFUSION, 2008, 48 (02) : 14A - 14A
  • [49] SEROLOGICAL AND IMMUNOLOGICAL CHARACTERISTICS OF MATERNAL ANTI-RH(D) ANTIBODIES IN PREDICTING THE SEVERITY OF HEMOLYTIC-DISEASE OF THE NEWBORN
    ZUPANSKA, B
    BROJER, E
    RICHARDS, Y
    LENKIEWICZ, B
    SEYFRIED, H
    HOWELL, P
    VOX SANGUINIS, 1989, 56 (04) : 247 - 253
  • [50] Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer
    Krog, Grethe R.
    Donneborg, Mette L.
    Hansen, Bo M.
    Lorenzen, Henriette
    Clausen, Frederik B.
    Jensen, Kristian V.
    Kjaerbye-Thygesen, Anette
    Albertsen, Per
    Ebbesen, Finn
    Bergholt, Thomas
    Smed, Mette K.
    Dziegiel, Morten H.
    PEDIATRIC RESEARCH, 2021, 90 (01) : 74 - 81
12345